Cognitive and Neurophysiological Effects of Raloxifene in Alzheimer's Disease
Status:
Completed
Trial end date:
2005-03-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to determine the effectiveness of treatment with raloxifene, an
estrogen-like medication approved by the Food and Drug Administration for the treatment of
osteoporosis, in improving memory and the ability to live independently in postmenopausal
women with Alzheimer's disease.